CanSino Biologics Statistics
Total Valuation
HKG:6185 has a market cap or net worth of HKD 12.02 billion. The enterprise value is 10.15 billion.
Market Cap | 12.02B |
Enterprise Value | 10.15B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HKG:6185 has 247.04 million shares outstanding. The number of shares has decreased by -1.38% in one year.
Current Share Class | 132.67M |
Shares Outstanding | 247.04M |
Shares Change (YoY) | -1.38% |
Shares Change (QoQ) | -7.33% |
Owned by Insiders (%) | 31.39% |
Owned by Institutions (%) | 7.63% |
Float | 159.10M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 141.65 |
PS Ratio | 12.90 |
PB Ratio | 2.29 |
P/TBV Ratio | 2.34 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -42.95 |
EV / Sales | 10.89 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -20.42 |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.27.
Current Ratio | 2.65 |
Quick Ratio | 2.41 |
Debt / Equity | 0.27 |
Debt / EBITDA | n/a |
Debt / FCF | -2.89 |
Interest Coverage | -4.88 |
Financial Efficiency
Return on equity (ROE) is -4.40% and return on invested capital (ROIC) is -2.58%.
Return on Equity (ROE) | -4.40% |
Return on Assets (ROA) | -2.17% |
Return on Invested Capital (ROIC) | -2.58% |
Return on Capital Employed (ROCE) | -4.55% |
Revenue Per Employee | 843,390 |
Profits Per Employee | -213,787 |
Employee Count | 1,105 |
Asset Turnover | 0.11 |
Inventory Turnover | 0.71 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.82% in the last 52 weeks. The beta is 1.18, so HKG:6185's price volatility has been higher than the market average.
Beta (5Y) | 1.18 |
52-Week Price Change | +59.82% |
50-Day Moving Average | 32.09 |
200-Day Moving Average | 29.19 |
Relative Strength Index (RSI) | 57.25 |
Average Volume (20 Days) | 1,287,259 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6185 had revenue of HKD 931.95 million and -236.23 million in losses. Loss per share was -0.97.
Revenue | 931.95M |
Gross Profit | 674.34M |
Operating Income | -305.35M |
Pretax Income | -239.00M |
Net Income | -236.23M |
EBITDA | -121.28M |
EBIT | -305.35M |
Loss Per Share | -0.97 |
Balance Sheet
The company has 3.31 billion in cash and 1.44 billion in debt, giving a net cash position of 1.87 billion or 7.59 per share.
Cash & Cash Equivalents | 3.31B |
Total Debt | 1.44B |
Net Cash | 1.87B |
Net Cash Per Share | 7.59 |
Equity (Book Value) | 5.25B |
Book Value Per Share | 22.75 |
Working Capital | 2.76B |
Cash Flow
In the last 12 months, operating cash flow was -78.15 million and capital expenditures -418.78 million, giving a free cash flow of -496.93 million.
Operating Cash Flow | -78.15M |
Capital Expenditures | -418.78M |
Free Cash Flow | -496.93M |
FCF Per Share | -2.01 |
Margins
Gross margin is 72.36%, with operating and profit margins of -32.76% and -25.35%.
Gross Margin | 72.36% |
Operating Margin | -32.76% |
Pretax Margin | -25.65% |
Profit Margin | -25.35% |
EBITDA Margin | -13.01% |
EBIT Margin | -32.76% |
FCF Margin | n/a |
Dividends & Yields
HKG:6185 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.38% |
Shareholder Yield | n/a |
Earnings Yield | -1.97% |
FCF Yield | -4.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKG:6185 has an Altman Z-Score of 1.93. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.93 |
Piotroski F-Score | n/a |